Mixing method influence on compatibility and polymorphism studies by DSC and statistical analysis

Journal of Thermal Analysis and Calorimetry - Tập 131 - Trang 2123-2128 - 2017
Elionai Cassiana de Lima Gomes1, Izabella Ercole de Carvalho2, Silvia Ligório Fialho3, Jamile Barbosa3, Maria Irene Yoshida1, Armando da Silva Cunha Júnior2
1Chemistry Department, Federal University of Minas Gerais, Belo Horizonte, Brazil
2Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil
3Ezequiel Dias Foundation (FUNED), Belo Horizonte, Brazil

Tóm tắt

Most of the pharmaceutical products are formulated as solid dosage form, which may present drug–excipient interactions that lead to changes in the chemical nature of the drug, such as solubility and bioavailability and may compromise its safety and effectiveness. Differential scanning calorimetry (DSC) is a widely used method for the rapid evaluation of the drug-excipient compatibility and the stability of the mixture formed; however, there is no consensus on the preparation methods of the drug–excipient mixtures. The aim of this study was to investigate the influence of the mixing method on the drug–excipient compatibility studies by means of DSC analysis, using tenofovir disoproxil fumarate as a drug model. Statistical analysis revealed significant differences in the heat of fusion of the drug in the mixtures prepared by several mixing methods. Vortex Mixer with a Pop-Off Cup used for 3 min proved to be very satisfactory for these studies. A polymorphic transition was observed in the mixture prepared with the mortar and pestle. Therefore, this method should be avoided since it may induce errors in the interpretation of DSC results. In this way, the mixing method used to prepare a mixture for studies of interactions between the API and the excipients in a pharmaceutical formulation has a great influence on the results and it must be chosen carefully.

Tài liệu tham khảo

Tonder ECV, Lotter AP, Botha SA. Compatibility study between Doxylamine Succinate with other Drugs. Drug Dev Ind Pharm. 1990;16:2125–33.